Literature DB >> 23138133

NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia.

L Mansouri, N Cahill, R Gunnarsson, K E Smedby, E Tjönnfjord, H Hjalgrim, G Juliusson, C Geisler, R Rosenquist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23138133     DOI： 10.1038/leu.2012.307

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  29 in total

1.  UGT2B17 expression: a novel prognostic marker within IGHV-mutated chronic lymphocytic leukemia?

Authors:  Sujata Bhoi; Panagiotis Baliakas; Diego Cortese; Mattias Mattsson; Marie Engvall; Karin E Smedby; Gunnar Juliusson; Lesley-Ann Sutton; Larry Mansouri
Journal:  Haematologica       Date:  2015-11-20       Impact factor: 9.941

2.  Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia.

Authors:  L Mansouri; L-A Sutton; V Ljungström; E F Sörqvist; R Gunnarsson; K E Smedby; G Juliusson; K Stamatopoulos; M Nilsson; R Rosenquist
Journal:  Leukemia       Date:  2013-10-31       Impact factor: 11.528

3.  SF3B1 mutations correlated to cytogenetics and mutations in NOTCH1, FBXW7, MYD88, XPO1 and TP53 in 1160 untreated CLL patients.

Authors:  S Jeromin; S Weissmann; C Haferlach; F Dicker; K Bayer; V Grossmann; T Alpermann; A Roller; A Kohlmann; T Haferlach; W Kern; S Schnittger
Journal:  Leukemia       Date:  2013-09-12       Impact factor: 11.528

4.  On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort.

Authors:  D Cortese; L-A Sutton; N Cahill; K E Smedby; C Geisler; R Gunnarsson; G Juliusson; L Mansouri; R Rosenquist
Journal:  Leukemia       Date:  2013-11-12       Impact factor: 11.528

5.  Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting.

Authors:  Lesley-Ann Sutton; Viktor Ljungström; Larry Mansouri; Emma Young; Diego Cortese; Veronika Navrkalova; Jitka Malcikova; Alice F Muggen; Martin Trbusek; Panagiotis Panagiotidis; Frederic Davi; Chrysoula Belessi; Anton W Langerak; Paolo Ghia; Sarka Pospisilova; Kostas Stamatopoulos; Richard Rosenquist
Journal:  Haematologica       Date:  2014-12-05       Impact factor: 9.941

Review 6.  Deciphering the molecular landscape in chronic lymphocytic leukemia: time frame of disease evolution.

Authors:  Lesley-Ann Sutton; Richard Rosenquist
Journal:  Haematologica       Date:  2015-01       Impact factor: 9.941

Review 7.  Molecular pathogenesis of CLL and its evolution.

Authors:  David Rodríguez; Gabriel Bretones; Javier R Arango; Víctor Valdespino; Elías Campo; Víctor Quesada; Carlos López-Otín
Journal:  Int J Hematol       Date:  2015-01-29       Impact factor: 2.490

Review 8.  Molecular basis of chronic lymphocytic leukemia diagnosis and prognosis.

Authors:  Mohammad Shahjahani; Javad Mohammadiasl; Fatemeh Noroozi; Mohammad Seghatoleslami; Saeid Shahrabi; Fakhredin Saba; Najmaldin Saki
Journal:  Cell Oncol (Dordr)       Date:  2015-01-07       Impact factor: 6.730

Review 9.  SF3B1 mutations in chronic lymphocytic leukemia.

Authors:  Youzhong Wan; Catherine J Wu
Journal:  Blood       Date:  2013-04-08       Impact factor: 22.113

10.  Cytogenetic complexity in chronic lymphocytic leukemia: definitions, associations, and clinical impact.

Authors:  Panagiotis Baliakas; Sabine Jeromin; Michalis Iskas; Anna Puiggros; Karla Plevova; Florence Nguyen-Khac; Zadie Davis; Gian Matteo Rigolin; Andrea Visentin; Aliki Xochelli; Julio Delgado; Fanny Baran-Marszak; Evangelia Stalika; Pau Abrisqueta; Kristina Durechova; George Papaioannou; Virginie Eclache; Maria Dimou; Theodoros Iliakis; Rosa Collado; Michael Doubek; M Jose Calasanz; Neus Ruiz-Xiville; Carolina Moreno; Marie Jarosova; Alexander C Leeksma; Panayiotis Panayiotidis; Helena Podgornik; Florence Cymbalista; Achilles Anagnostopoulos; Livio Trentin; Niki Stavroyianni; Fred Davi; Paolo Ghia; Arnon P Kater; Antonio Cuneo; Sarka Pospisilova; Blanca Espinet; Anastasia Athanasiadou; David Oscier; Claudia Haferlach; Kostas Stamatopoulos
Journal:  Blood       Date:  2019-01-02       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.